Bortecade (bortezomib) for injection is supplied as individually cartoned 10 ml vials containing 3.5 mg of bortezomib as a white to off-white cake or powder.
Bortecade (bortezomib) for injection is an antineoplastic agent available for intravenous injection (IV) use only.
Each single dose vial contains 3.5 mg of bortezomib as a sterile lyophilized powder.
Excipients/Inactive Ingredients: 35 mg mannitol EP.
                                
                            Other Services
                            
                            
                            Country
                            Account
                            
                        
                
                                    
                                            
 Sign Out